To the full analysis
Aveanna Healthcare Holdings stock: growth
AVAHAveanna Healthcare Holdings reported $2.43B in revenue for fiscal 2025, up 20.2% on the prior year, up 10.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9.9%
per year from 2018 to 2025, per share 8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
78.9%
per year from 2018 to 2025, per share 75.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2018 | |
|---|---|---|
| Revenue | 10.2% | 9.9% |
| Revenue per share | 8.3% | 8.0% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | 3.2% | 78.9% |
| Free cash flow per share | 1.3% | 75.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2018 | $1.25B | −$47.15M | $2.02M |
| 2019 | $1.38B | −$76.52M | −$25.35M |
| 2020 | $1.5B | −$57.05M | $101.38M |
| 2021 | $1.68B | −$117.04M | −$27.3M |
| 2022 | $1.79B | −$662.03M | −$60.42M |
| 2023 | $1.9B | −$134.52M | $16.56M |
| 2024 | $2.02B | −$10.93M | $26.32M |
| 2025 | $2.43B | $225.03M | $118.41M |
Revenue by segment
How Aveanna Healthcare Holdings Inc. makes its money and how that has shifted. Names are as the company reports them.
- Private Duty Services82%
- Home Health And Hospice10%
- Medical Solutions8%
Figures as a table
| 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|
| Private Duty Services | $1.36B | $1.42B | $1.52B | $1.63B | $2B | 82.2% |
| Home Health And Hospice | $177.27M | $232.58M | $218.63M | $217.81M | $248.56M | 10.2% |
| Medical Solutions | $143.23M | $139.96M | $157.77M | $172.09M | $183.5M | 7.5% |
| Total revenue | $1.68B | $1.79B | $1.9B | $2.02B | $2.43B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 3 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Nov 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.